Jump Financial’s Akoya BioSciences AKYA Stock Holding History

Jump Financial’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,700	Closed	-$160K	–	1542
2022 Q4	$160K	Buy	+16,700	New	+$205K	0.01%	1347

Other funds holding AKYA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Altium Capital Management New York $42M AUM

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Jump Financial's AKYA Position: Q1 2023 in Review

Jump Financial sold out of Akoya BioSciences (AKYA) in Q1 2023, closing a stake of 16,700 shares — an estimated $160K sold.

Jump Financial first reported a position in AKYA in Q4 2022 and held it in 1 quarter. The position peaked at $160K in Q4 2022. 63 funds tracked by Wall St. Rank hold AKYA as of Q1 2023.

Jump Financial reported no remaining Akoya BioSciences position as of Q1 2023 after selling out during the quarter.
Jump Financial sold 16,700 Akoya BioSciences shares in Q1 2023, an estimated $160K.
Jump Financial first reported a position in Akoya BioSciences in Q4 2022 and held it in 1 quarter.
Jump Financial's Akoya BioSciences position peaked at $160K in Q4 2022.
63 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2023.

Based on Jump Financial's 13F filing for Q1 2023, filed 3 May 2023.